Cite
HARVARD Citation
Buttgereit, F. et al. (n.d.). SAT0221 Efficacy and Safety of PF-04171327, a Novel Dissociated Agonist of the Glucocorticoid Receptor (DAGR): Results of a Phase 2, Randomized, Double-Blind Study. Annals of the rheumatic diseases. pp. 737-738. [Online].